Navigation Links
Cardium Presents First Quarter 2013 Financial Results And Reports On Recent Developments
Date:5/15/2013

oducts; (2) increasing online customer acquisition and retention by introducing super affiliate programs and social media-based coupon offerings (e.g. LivingSocial); (3) expanding and leveraging the VitaRocks children's vitamin product line; and (4) expanding U.S. retail distribution and establishing international distributors to leverage on the success of To Go Brands' lead product, Trim Green Coffee Bean™ dietary supplement.

Cardium's In-House InitiativesThe Company recently announced its partner-enabled internal product development, LifeAgain™, a medical analytics and e-commerce platform that is focused on the development, marketing and direct sales of new and innovative survivable risk, multi-year, non-convertible level term life insurance programs and other insurance products, that are currently non-accessible and unaffordable for certain sub-groups of highly motivated buyers considered "uninsurable" based on traditional underwriting standards by U.S. life insurance companies. 

In addition, the Company announced the potential for a partner-enabled pilot Phase 2b/3 clinical study for Genedexa™ (Ad5PDGF-B), formerly referred to as the Company's Excellarate product candidate.  Genedexa's initial clinical development focus will be for the treatment of chronic, non-healing diabetic foot ulcers.  The Company may use alternative independent private financings and strategic partners to finance the clinical development of Genedexa and commercialize its LifeAgain platform. 

About CardiumCardium is an asset-based health sciences and regenerative medicine company focused on the acquisition and strategic development of innovative products and businesses with the potential to address significant unmet medical needs and having definable pathways to commercialization, partnering or other economic monetizations. Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the Company's newly-
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Cardium Announces Generx Publication In Molecular Therapy
2. Cardium Announces Excellagen Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting
3. Cardium Presents Year-End 2012 Financial Results And Recent Developments
4. Cardium Announces $4.0 Million Preferred Stock Financing And Reports On Exchange Listing Compliance
5. Cardium Receives ISO Certification for Excellagen
6. Cardium Announces Presentaton at The 2013 Cell & Gene Therapy Forum
7. Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
8. Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
9. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
10. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
11. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... YORK , September 23, 2014 ... pioneer in computer-aided dysmorphology analysis will exhibit at the ... Diego, CA. FDNA will present the latest ... and reference solution, using facial analysis technology. Face2Gene facilitates ... of human malformations from facial photos. The ...
(Date:9/23/2014)... , Sept. 23, 2014  Medela announced today ... Biomedical Company (ABC), assigning Medela as the exclusive distributor ... known as the Medela Enteral Feeding Pump. Through this ... help NICU parents and healthcare professionals by offering a ... Medela Enteral Feeding Pump is integral to the delivery ...
(Date:9/23/2014)... N.J. , Sept. 23, 2014  Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today that it has appointed ... President of Biopharmaceutical Development.  Dr. Arumugham has over ... and development (R&D) in the areas of formulation ...
Breaking Medicine Technology:FDNA to Exhibit at ASHG2014 Presenting Face2Gene Integrated With London Medical Databases (LMD) Online 2Medela Enters Exclusive Enteral Feeding Pump Agreement with Atlanta Biomedical Company 2Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development 2Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development 3Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development 4
... HbA1c reductions seen in ischemic patients with ... diabetes in earlier clinical trials -, ... ) announced today that data from a prospectively identified,analysis of ... (ranolazine extended-release tablets) significantly reduced,hemoglobin A1c (HbA1c), increased the number ...
... Cleveland Clinic Researchers Highlight the Need For More Women to ... ... Cleveland Clinic,researchers have recently found that women remain a significant ... and Blood Institute (NHLBI). Lead Author, Esther S.H. Kim, ...
Cached Medicine Technology:CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36 2CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36 3CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36 4Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates 2
(Date:9/23/2014)... September 23, 2014 With summer at ... in spirit and weather), organic food manufacturing company Earth ... month centered on sweet treats for the whole family. ... bite-sized candies by the handful in celebration of the ... recent years these festivities come with an increasing degree ...
(Date:9/23/2014)... IL (PRWEB) September 23, 2014 ... solutions, has expanded its MedMaster™ M4 product line ... luminaire extends the M4 product line – currently ... LED options – providing more flexibility when designing ... the MedMaster M4 Series include:, •Three ...
(Date:9/23/2014)... On September 20- 21, 2014, people ... two days of Trivedi Retreat ‘Consciousness is Power’, online ... the Energy Transmissions from Mahendra Trivedi and Trivedi Masters™ ... people enjoyed the In-person, group and live Energy Transmissions ... Trivedi and Trivedi Master™ Alice Branton, where, they described ...
(Date:9/23/2014)... (HealthDay News) -- Pregnant women appear to have an ... a new study. And this strong immune ... from the flu than other healthy adults. The reason: ... immune system responding to the virus, the researchers said. ... that pregnancy weakens the immune system to keep it ...
(Date:9/23/2014)... On September 8th, the company XenOPAT SL, a spin-off ... Catalan Institute of Oncology (ICO) was established with the ... to the service combating cancer with two main branches: ... of personalized cancer treatments. , Orthotopic models and ... the use of orthotopic models (orthoxenograft) mouse by implantation ...
Breaking Medicine News(10 mins):Health News:Righteously Raw Chocolates Promote Healthy, Fun Snacking this Fall Season 2Health News:Kenall Expands MedMaster™ M4 Surgical Suite Product Portfolio with New 1'×4' Option 2Health News:Kenall Expands MedMaster™ M4 Surgical Suite Product Portfolio with New 1'×4' Option 3Health News:The Trivedi Retreat ‘Consciousness is Power’ was Huge Success 2Health News:The Trivedi Retreat ‘Consciousness is Power’ was Huge Success 3Health News:Study Suggests Why Pregnant Women Get Sicker From Flu 2Health News:Study Suggests Why Pregnant Women Get Sicker From Flu 3Health News:XenOPAT, mouse models for personalized cancer treatment 2
... ... ... ... ...
... ... ... ... ...
... ... ... , ... TULSA, Okla. , Feb. 19 U.S. ...
... more fumes that are likely carcinogenic than with electric ranges ... hot stove -- make that a hot gas ... cancer. , Researchers in Norway have found that cooking with ... , But, in a report published online Feb. 17 in ...
... (P4P) programs are payment models that reward workers for ... the healthcare setting, P4P programs use a variety of ... fee differentials and bonuses. A new study ... that P4P programs appear to be effective in incentivizing ...
... ... momentum created by local communities and the NGO Tostan to end the practice by 2015 ... Dakar, Senegal (PRWEB) February ... cutting (FGC) which has seen thousands of communities in Senegal join its ranks in recent ...
Cached Medicine News:Health News:New Gallup Poll Quantifies U.S. Physician Opinions on the Scope of Defensive Medicine Practices 2Health News:New Gallup Poll Quantifies U.S. Physician Opinions on the Scope of Defensive Medicine Practices 3Health News:New Gallup Poll Quantifies U.S. Physician Opinions on the Scope of Defensive Medicine Practices 4Health News:Abbott Announces 10 Percent Increase in Quarterly Dividend 2Health News:Abbott Announces 10 Percent Increase in Quarterly Dividend 3Health News:Two Tulsa Pharmacies Penalized for Missing Prescription Drugs 2Health News:Two Tulsa Pharmacies Penalized for Missing Prescription Drugs 3Health News:Gas Cooking Might Up Your Cancer Risk 2Health News:Gas Cooking Might Up Your Cancer Risk 3Health News:Senegal: Total End of Female Genital Cutting Now in Sight 2
... The 1700 Series Outpatient Surgical Table ... standards as Skytron's other specialty and general ... their key features such as 180-degree top ... extremely durable side rails will accommodate a ...
23" Top Slide with Full Table Functions for Every Procedure...
... operating table for any application. The ... unlimited C-arm access. High stability guarantees ... and cardiovascular procedures. An extension device ... can easily be attached for orthopedic ...
As with all Eschmann products the T20 operating table was designed with 'Simplicity and Intuitiveness' in mind, having drawn influences from leading clinicians of various levels from across the globe...
Medicine Products: